Rossmax International Ltd. (4121) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Rossmax International Ltd. (4121:TWSE), powered by AI.

Current Price
$13.65
Sector
Healthcare
What is the Rossmax International Ltd. stock price forecast?

Rossmax International Ltd. is currently trading at $13.65. View real-time AI analysis on Alpha Lenz.

What is Rossmax International Ltd. insider trading activity?

View the latest insider trading data for Rossmax International Ltd. on Alpha Lenz.

What is Rossmax International Ltd.'s P/E ratio?

View Rossmax International Ltd.'s valuation metrics on Alpha Lenz.

Rossmax International Ltd.

TWSE · 4121
NT$13.65+0.15(+1.11%)
Ask about Rossmax International Ltd.'s future dividend policy...
Alpha Chat Insight

Rossmax International Ltd.'s ROE is -2.1%. Explore profitability and growth together.

Ask for details

Company Overview

Rossmax International Ltd. is a healthcare equipment manufacturer based in Taipei, Taiwan, specializing in the design, production, and global distribution of medical devices. The company’s core activities span the fields of prevention, monitoring, and therapy, offering a comprehensive range of products including blood pressure monitors, digital thermometers, nebulizers, personal scales for fitness and obesity management, and advanced solutions for respiratory care, fever management, and pain therapy. Rossmax International is recognized for its technological innovation, holding numerous patents, and for being among the first outside Japan to manufacture wrist blood pressure monitors with dual-user memory functions. The company’s commitment to clinical validation and quality standards is reflected in its certifications such as FDA and CE Mark. Serving healthcare providers and consumers in over 90 countries, Rossmax plays a significant role in advancing home and clinical health diagnostics, supporting the growing global emphasis on preventive healthcare and chronic disease management. With its fully integrated manufacturing facilities and continuous research and development, Rossmax International is a notable player in the medical equipment and healthcare technology sectors.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$3.80BRevenue
0.00Shares Out
0Employees

Margins

34.38%Gross
8.11%EBITDA
-1.91%Operating
-1.64%Pre-Tax
-1.81%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-4.37%Rev 3Yr
0.65%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.63%ROA
-2.07%ROE
-0.82%ROIC

Financial Health

NT$613.70MCash & Cash Equivalents
NT$1.61BNet Debt
112.12%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Rossmax International Ltd. (ticker: 4121) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 13.65 with a P/E ratio of -x and P/B of -x.

ROE is -2.07% and operating margin is -1.91%. Annual revenue is $3.8B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Rossmax International Ltd. (4121) Stock Forecast 2026 $13.65 — Price, Financials & Analyst Targets | Alpha Lenz